Home › Bayer spending $100 million on Berkeley hemophilia drug facility
 

Keywords :   


Bayer spending $100 million on Berkeley hemophilia drug facility

2015-04-30 00:03:51| Chemicals - Topix.net

Bayer HealthCare is spending $100 million over the next two years building a product testing facility here for a new hemophilia drug, a project that will create 325,000 hours of construction work, officials said during a news conference Wednesday. Bayer's Berkeley campus, which spans three city blocks on 7th Street between Dwight Way and Grayson Street, manufactures a drug for people with hemophilia A called Kogenate.

Tags: million drug facility spending

Category:Chemicals

Latest from this category

All news
05.11BASF Opens New Production Line in Heerenveen, the Netherlands
05.11Registration Now Open for RadTech 2025
05.11Teknos Poland Honored by Farby i Lakiery
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
04.11Registration Open for 2025 Waterborne Symposium
04.11ROSS Ribbon Blenders Provide Safe, Efficient Bulk Blending
04.11U.S. Green Building Council Announces 2024 Leadership Award Recipients
04.11ASTM International Publishes New Standards for FT4 Powder Rheometer Procedures
Chemicals »
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »